Tag Archives: recombinant

Hong Kong listed WuXi Biologics to operate Bayer’s final drug product manufacturing plants in Leverkusen, Germany

Plants in Leverkusen will be operated by WuXi Biologics and will serve as a back-up site for final product manufacturing of Kovaltry™

(PRESS RELEASE) LEVERKUSEN, 16-Jan-2020 — /EuropaWire/ —  Life science, health care and nutrition global enterprise Bayer announced that the leading global open-access biologics technology firm WuXi Biologics (WuXi Bio), listed in Hong Kong (stock code: 2269.HK), through its subsidiary in … Read the full press release